|
Boston University Scleroderma Program, Doctor’s
Office Building, Boston University Medical Center, 720
Harrison Avenue, Boston, MA 02118
http://medicine.bu.edu/sc/sclero.htm
Clinic Information:
Adult, adolescent and pediatric patients seen with systemic
and localized scleroderma
Hours: Monday–Friday, 9 a.m.–5 p.m.
dependent on individual doctor’s office hours.
Appointments: Mary Lou Kemp, 617-638-4312 or
Kate Brennan 617-638-4486
Physician Inquiries: 617-638-4312 or 617-638-4486
Research Information:
Kerry Viger 617-638-4344, Kim Tobin 617-638-7503 or
Kate Brennan 617-638-4486
| Studies |
Status |
| BUILD 2 Open-label Bosentan for Interstitial Lung
Disease |
Limited to current participants |
| Rituximab open-label trial for early diffuse skin
involvement |
Recruiting |
| RAPIDS open-label Bosentan for treatment of digital
ulcers |
Limited to current participants |
| Sitaxentan for pulmonary hypertension and interstitial
lung disease |
Recruiting |
| SCOT (Scleroderma Cyclophosphamide or Transplantation) |
Recruiting |
| Scleroderma lung study (Funded by NIH) |
Closed |
| Oral collagen study (NIH) |
Closed |
| BUILD 2 |
Closed |
Physicians Affiliated with
this Center:
- Robert Simms, M.D.
- Robert Lafyatis, M.D.
- Peter Merkel, M.D.
- Eugene Kissin, M.D.
- Sohail Ahmed, M.D.
|
